Gastro-intestinal complement activation during human liver transplantation: impact on postoperative liver function

Area of Science:

• Immunology
• Transplantation Medicine
• Gastroenterology

Background:

• Liver transplantation triggers systemic inflammation and potential multiple organ failure.
• Gastro-intestinal inflammatory activation, including cytokine and complement release, may precede organ dysfunction.
• The study investigates the link between gastro-intestinal complement activation and liver injury post-transplant.

Purpose of the Study:

• To evaluate gastro-intestinal complement activation in liver transplant recipients.
• To determine the association between gastro-intestinal complement activation and postoperative liver cell injury.
• To assess the relationship with overall liver dysfunction after transplantation.

Main Methods:

• Studied 17 liver transplant patients, measuring complement SC5b-9 and endotoxin in radial artery and portal vein.
• Calculated portal venous-arterial SC5b-9 plasma concentration gradients post-reperfusion.
• Monitored postoperative organ failure and serum levels of liver enzymes (AST, ALT), bilirubin, and coagulation factors (II-VII-X).

Main Results:

• Patients with gastro-intestinal SC5b-9 release showed significantly higher AST and ALT levels post-surgery.
• Lower levels of factor II-VII-X were observed in patients with gastro-intestinal complement activation.
• Prolonged ICU stay was noted in patients with gastro-intestinal complement release; endotoxin levels were low and poorly correlated with complement activation.

Conclusions:

• Gastro-intestinal complement activation appears to contribute to liver cell injury and dysfunction following liver transplantation.
• This activation pathway is a potential factor in the development of post-transplant liver complications.